Response to neoadjuvant chemo for breast cancer varies by sex

Summary by Ground News

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy are numerically lower. The analysis included 385 men and 68,065 women with BC treated with NAC. Women had twice the odds of pCR than men with BC (adjusted odds ratio, 2.0)

2 months ago·O' Neill, United States

News Articles

More Filters

All

Left

Center

Right

Medical Xpress

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, according to a study published online Sept. 7 in Cancer.

2 months ago

Read Full Article

HealthDay

Response to Neoadjuvant Chemo for Breast Cancer Varies by Sex

THURSDAY, Oct. 6, 2022 (HealthDay News) -- Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus

2 months ago

Read Full Article